Author

Joanna L. Donatelli

Gilead Sciences (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Assay:CRISPR screen· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Derek K. SmithiD· 2 shared Ramya Ankala· 2 shared Alain NoncovichiD· 1 shared Allen Borchardt· 1 shared Amanda L. Almaguer· 1 shared Arun Dhama· 1 shared Chris Regens· 1 shared Collin McGregor· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Derek K. SmithORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

An AI/ML-Powered Workflow for End-to-End Cell Line Development

Shalini Raj Unnikandam Veettil, Joanna L. Donatelli, Geetansh Kalra, Constanza Verónica Ljubetic San Martín, Shankar Ram Ramakrishnan, Collin McGregor, Michelle Wallace, Ramya Ankala, Leonardo Rodrigues de Souza Pinto, Arun Dhama, Chris Regens, Y. Li, Derek K. Smith

This paper develops a deep learning tool for automating cell line development, achieving a 36-day workflow for generating high-titer antibody-producing cell lines.

bioRxiv · Feb 7, 2026 · PreprintCell Biology

An Efficient Workflow for CHO Cell Genome Engineering with OpenCRISPR-1

Divya Kolakada, Ramya Ankala, Joanna L. Donatelli, Derek K. Smith

This paper validates OpenCRISPR-1 in CHO cells, achieving ≥70% INDEL efficiency across multiple genes using a 39-day workflow.

bioRxiv · Dec 20, 2025 · PreprintBioengineering

CD388: A universally protective Drug-Fc Conjugate that targets influenza virus neuraminidase

Simon Döhrmann, James M Levin, Jason N. Cole, Allen Borchardt, Karin Amundson, Amanda L. Almaguer, Elizabeth Abelovski, Rajvir Grewal, Douglas E. Zuill, Nicholas Dedeic, Grayson Hough, Joanne Fortier, Joanna L. Donatelli, Thanh Lam, Zhiyong Chen, , Leslie W. Tari

This paper describes CD388, a drug-Fc conjugate that targets influenza virus neuraminidase, showing universal antiviral activity across multiple strains and demonstrating efficacy in mouse models.

Nature Microbiology · Mar 17, 2025Peer-reviewedMicrobiology